Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.

Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.

Detalles Bibliográficos
Autor Principal: Armitage, J
Formato: Journal article
Idioma:English
Publicado: 2008
Descripción
Summary:

Títulos similares